Literature DB >> 11689449

A specific lysine in c-Jun is required for transcriptional repression by E1A and is acetylated by p300.

R G Vries1, M Prudenziati, C Zwartjes, M Verlaan, E Kalkhoven, A Zantema.   

Abstract

The adenovirus E1A protein regulates transcription of cellular genes via its interaction with the transcriptional coactivators p300/CBP. The collagenase promoter activated by the c-Jun protein is repressed by E1A. Here we show that E1A repression is specific for c-Jun, as E1A does not repress the collagenase promoter activated by the homologous transcription factor EB1. Using chimeras of c-Jun and EB1, we demonstrate that a 12 amino acid region in the basic region of the c-Jun DNA-binding domain is essential for repression by E1A. Since repression requires the binding of p300 to E1A, we studied the involvement of p300 acetyltransferase activity in the repression mechanism. We demonstrate that c-Jun is acetylated in vivo, and mutational analysis identified Lys271 in the c-Jun basic region to be essential for repression of the collagenase promoter by E1A. In addition, Lys271 is acetylated both in vitro and in vivo. These results suggest that the specific repression of the collagenase promoter by E1A involves acetylation of c-Jun.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11689449      PMCID: PMC125698          DOI: 10.1093/emboj/20.21.6095

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  56 in total

Review 1.  Histone acetylation in chromatin structure and transcription.

Authors:  M Grunstein
Journal:  Nature       Date:  1997-09-25       Impact factor: 49.962

Review 2.  Targeting chromatin disruption: Transcription regulators that acetylate histones.

Authors:  A P Wolffe; D Pruss
Journal:  Cell       Date:  1996-03-22       Impact factor: 41.582

Review 3.  AP-1 function and regulation.

Authors:  M Karin; Z g Liu; E Zandi
Journal:  Curr Opin Cell Biol       Date:  1997-04       Impact factor: 8.382

4.  Biochemical analysis of distinct activation functions in p300 that enhance transcription initiation with chromatin templates.

Authors:  W L Kraus; E T Manning; J T Kadonaga
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

5.  The TAF(II)250 subunit of TFIID has histone acetyltransferase activity.

Authors:  C A Mizzen; X J Yang; T Kokubo; J E Brownell; A J Bannister; T Owen-Hughes; J Workman; L Wang; S L Berger; T Kouzarides; Y Nakatani; C D Allis
Journal:  Cell       Date:  1996-12-27       Impact factor: 41.582

Review 6.  Acetylation of general transcription factors by histone acetyltransferases.

Authors:  A Imhof; X J Yang; V V Ogryzko; Y Nakatani; A P Wolffe; H Ge
Journal:  Curr Biol       Date:  1997-09-01       Impact factor: 10.834

Review 7.  Modulation of AP-1/ATF transcription factor activity by the adenovirus-E1A oncogene products.

Authors:  B M Hagmeyer; P Angel; H van Dam
Journal:  Bioessays       Date:  1995-07       Impact factor: 4.345

8.  The N-terminal region of the adenovirus type 5 E1A proteins can repress expression of cellular genes via two distinct but overlapping domains.

Authors:  J C Dorsman; B M Hagmeyer; J Veenstra; P Elfferich; N Nabben; A Zantema; A J van der Eb
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

9.  Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300.

Authors:  J S Lee; K M Galvin; R H See; R Eckner; D Livingston; E Moran; Y Shi
Journal:  Genes Dev       Date:  1995-05-15       Impact factor: 11.361

10.  Stimulation of c-Jun activity by CBP: c-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro.

Authors:  A J Bannister; T Oehler; D Wilhelm; P Angel; T Kouzarides
Journal:  Oncogene       Date:  1995-12-21       Impact factor: 9.867

View more
  27 in total

1.  Cascade of distinct histone modifications during collagenase gene activation.

Authors:  Joost H A Martens; Matty Verlaan; Eric Kalkhoven; Alt Zantema
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

Review 2.  Regulation of the inflammatory response of vascular endothelial cells by EPAC1.

Authors:  Euan Parnell; Brian O Smith; Timothy M Palmer; Anna Terrin; Manuela Zaccolo; Stephen J Yarwood
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

3.  Binding site specificity and factor redundancy in activator protein-1-driven human papillomavirus chromatin-dependent transcription.

Authors:  Wei-Ming Wang; Shwu-Yuan Wu; A-Young Lee; Cheng-Ming Chiang
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

4.  Stimulation of DNA replication from the polyomavirus origin by PCAF and GCN5 acetyltransferases: acetylation of large T antigen.

Authors:  An-Yong Xie; Vladimir P Bermudez; William R Folk
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

5.  Predicting transcription factor synergism.

Authors:  Sridhar Hannenhalli; Samuel Levy
Journal:  Nucleic Acids Res       Date:  2002-10-01       Impact factor: 16.971

Review 6.  Role of desumoylation in the development of prostate cancer.

Authors:  Jinke Cheng; Tasneem Bawa; Peng Lee; Limin Gong; Edward T H Yeh
Journal:  Neoplasia       Date:  2006-08       Impact factor: 5.715

7.  The diversity of histone versus nonhistone sirtuin substrates.

Authors:  Paloma Martínez-Redondo; Alejandro Vaquero
Journal:  Genes Cancer       Date:  2013-03

8.  The Roles of SIRT1 in Cancer.

Authors:  Zhenghong Lin; Deyu Fang
Journal:  Genes Cancer       Date:  2013-03

9.  A novel Arabidopsis acetyltransferase interacts with the geminivirus movement protein NSP.

Authors:  Roisin C McGarry; Yoshimi D Barron; Miguel F Carvalho; Janet E Hill; Daniel Gold; Edwin Cheung; W Lee Kraus; Sondra G Lazarowitz
Journal:  Plant Cell       Date:  2003-07       Impact factor: 11.277

Review 10.  The importance of being flexible: the case of basic region leucine zipper transcriptional regulators.

Authors:  Maria Miller
Journal:  Curr Protein Pept Sci       Date:  2009-06       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.